miRecule
United States · $5.7M raised
- Business Model
- B2B
- Website
- mirecule.com
- Total Funding
- $5.7M
- Last Round
- $5.7M SeedMay 2021
- Rounds
- 1
About
Biotechnology company developing RNA therapies for cancer and muscular dystrophy.
Summary
miRecule is a Biotech company based in United States. It has raised $5.7M in total across 1 round, most recently a $5.7M Seed round in May 2021. Investors include Alexandria Venture Investments, Alumni Ventures and Boutique Venture Partners.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...